Therapure Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Therapure Biopharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10923
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Therapure Biopharma Inc (Therapure) is a biotherapeutics company that enhances patient care through its three divisions: therapure biomanufacturing, therapure innovations and evolve biologics. The company’s therapure biomanufacturing division offers pipeline products such as TBI 301, TBI 302 and TBI 304H. Its company’s therapure innovations operate as a proprietary drug development division and uses proprietary protein technologies for the treatment of diseases such as anemia, liver cancer, and hepatitis C. Therapure’s services include purification, development, manufacture, and packaging of therapeutic proteins and follow-on biologics. The company operates through bio-pharmaceutical companies in across the world. Therapure is headquartered in Mississauga, Ontario, Canada.

Therapure Biopharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapure Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Therapure Biopharma To Acquire Plasma Protein Purification Technology From Upfront Chromatography 10
Private Equity 12
Catalyst Capital Group May Sell Therapure Biopharma for USD300 Million 12
Equity Offering 13
Therapure Biopharma Postpones IPO 13
Asset Transactions 14
10363782 Canada to Acquire CDMO Business from Therapure Biopharma for USD290 Million 14
Therapure Biopharma Inc – Key Competitors 15
Therapure Biopharma Inc – Key Employees 16
Therapure Biopharma Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Mar 23, 2018: Therapure Biopharma Launches Biologics Division as Evolve Biologics, an Innovative Plasma-Derived Therapeutics Company 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapure Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapure Biopharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Therapure Biopharma To Acquire Plasma Protein Purification Technology From Upfront Chromatography 10
Catalyst Capital Group May Sell Therapure Biopharma for USD300 Million 12
Therapure Biopharma Postpones IPO 13
10363782 Canada to Acquire CDMO Business from Therapure Biopharma for USD290 Million 14
Therapure Biopharma Inc, Key Competitors 15
Therapure Biopharma Inc, Key Employees 16
Therapure Biopharma Inc, Other Locations 17

List of Figures
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Therapure Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析
    Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Agilvax Inc-製薬・医療分野:企業M&A・提携分析
    Summary Agilvax Inc (Agilvax) is a drug company that discovers and develops vaccines against infectious diseases and immunotherapies to treat cancer. The company develops products based on a proprietary virus-like particle platform technology. It develops immunotherapies to treat breast cancer, lung …
  • Lockheed Martin Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Lockheed Martin Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Vaxil Bio Ltd (VXL):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaxil Bio Ltd (Vaxil Bio), formerly Emerge Resources Corp, is a drug development company that develops immunotherapy platform. The company’s immunptherapy pipeline products include antigen specific immunotherapies, signal peptide specific antibodies and anti-infectives. It develops Vaxhit te …
  • Cobb Electric Membership Corporation:発電所・企業SWOT分析
    Cobb Electric Membership Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Washington University in St Louis-製薬・医療分野:企業M&A・提携分析
    Summary Washington University in St Louis (Washington University), a subsidiary of University of Washington is an educational university that provides patient care and research services in the US. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range o …
  • NextEra Energy, Inc.:企業の戦略・SWOT・財務情報
    NextEra Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary NextEra Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bioxyne Ltd (BXN):企業の財務・戦略的SWOT分析
    Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CMS Energy Corporation (CMS):電力:M&Aディール及び事業提携情報
    Summary CMS Energy Corporation (CMS Energy) is an energy utility which provides electricity, natural gas, and banking services. It generates, procures, transmits, distributes, and sells energy. The company produces power from coal, oil and gas, hydro, wind, and solar sources. CMS Energy purchases, t …
  • Rompetrol Rafinare SA (RRC):企業の財務・戦略的SWOT分析
    Rompetrol Rafinare SA (RRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Source BioScience Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Source Bioscience Ltd (Source BioScience), a subsidiary of Sherwood Holdings Ltd is a provider of laboratory products and services. The company offers life science research, clinical product, and controlled environment products. Its life science research products include antibodies, clones, …
  • Multan Electric Power Company:企業の戦略的SWOT分析
    Multan Electric Power Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Crescent Point Energy Corp (CPG):企業の財務・戦略的SWOT分析
    Crescent Point Energy Corp (CPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • The InterTech Group Inc:企業の戦略的SWOT分析
    The InterTech Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Harvard Bioscience Inc (HBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets scientific instruments systems and lab consumables. The company’s product portfolio encompasses physiology, cell, molecular instruments products; electrophysiology products; and laboratory products and supplies. I …
  • Luye Pharma Group Ltd (2186):製薬・医療:M&Aディール及び事業提携情報
    Summary Luye Pharma Group Ltd (Luye Pharma Group) is a drug company that manufactures, develops, discovers, and commercializes novel formulations, natural drugs, medicinal products, pharmaceutical products, and biotechnology products. The group’s products include paclitaxel liposome, lentinan, sodiu …
  • Simona AG (SIM):企業の財務・戦略的SWOT分析
    Summary Simona AG (Simona) is a chemical company that manufactures and distributes chemicals and thermoplastic products. The company offers products such as pipes and fittings, semi-finished products, and finished parts, among others. Its semi-finished plastics include profiles, plates, rods, and we …
  • Panasonic Corporation (6752):企業の財務・戦略的SWOT分析
    Panasonic Corporation (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Axcelis Technologies Inc (ACLS):企業の財務・戦略的SWOT分析
    Summary Axcelis Technologies Inc (Axcelis) operates as a technology company that provides industrial equipment and services for semiconductor industries. The company’s offers ion implantation product, which include high current implanters, purion H, optima HDx, high energy purion XE, optima XEx, par …
  • Coutts & Co:企業の戦略・SWOT・財務分析
    Coutts & Co - Strategy, SWOT and Corporate Finance Report Summary Coutts & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆